Holdings of First Trust Nasdaq Pharmaceuticals ETF
First Trust Exchange-Traded Fund VI · Original filing · Compare with another fund · Report an error
- Net assets
- 29.2M $ including 29.1M $ in equities, 99.9 %
- Positions
- 50 in 3 countries
- Top ten
- 54.1 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 8,893 | 2.2M $ | 7.45 % |
| 2 | Bristol-Myers Squibb Co | 35,422 | 2.1M $ | 7.36 % |
| 3 | Merck & Co Inc | 17,843 | 2.1M $ | 7.36 % |
| 4 | AbbVie Inc | 9,520 | 2.1M $ | 7.10 % |
| 5 | Eli Lilly & Co | 2,100 | 1.9M $ | 6.62 % |
| 6 | Pfizer Inc | 39,951 | 1.1M $ | 3.85 % |
| 7 | Regeneron Pharmaceuticals, Inc. | 1,413 | 1.1M $ | 3.74 % |
| 8 | Biogen Inc | 5,759 | 1.1M $ | 3.62 % |
| 9 | Gilead Sciences Inc | 7,416 | 1M $ | 3.54 % |
| 10 | Cardinal Health, Inc. | 4,819 | 1M $ | 3.49 % |
| 11 | Amgen Inc | 2,846 | 1M $ | 3.43 % |
| 12 | Viatris Inc | 73,989 | 999.6K $ | 3.43 % |
| 13 | Zoetis Inc | 8,426 | 996K $ | 3.41 % |
| 14 | Vertex Pharmaceuticals Inc | 2,223 | 992.7K $ | 3.40 % |
| 15 | United Therapeutics Corp | 1,630 | 966.6K $ | 3.31 % |
| 16 | Incyte Corp | 6,843 | 644.1K $ | 2.21 % |
| 17 | Jazz Pharmaceuticals PLC | 3,347 | 632.8K $ | 2.17 % |
| 18 | Illumina Inc | 3,657 | 450.8K $ | 1.55 % |
| 19 | Exelixis Inc | 10,279 | 440.9K $ | 1.51 % |
| 20 | Medpace Holdings Inc | 865 | 415.4K $ | 1.42 % |
| 21 | PTC Therapeutics Inc | 5,449 | 371.2K $ | 1.27 % |
| 22 | Charles River Laboratories International Inc | 2,127 | 366.9K $ | 1.26 % |
| 23 | BioMarin Pharmaceutical Inc | 6,318 | 356.9K $ | 1.22 % |
| 24 | Neurocrine Biosciences Inc | 2,630 | 346.5K $ | 1.19 % |
| 25 | Halozyme Therapeutics Inc | 5,005 | 323.5K $ | 1.11 % |
| 26 | Alkermes PLC | 8,380 | 296.3K $ | 1.02 % |
| 27 | Elanco Animal Health Inc | 10,925 | 261.4K $ | 0.90 % |
| 28 | Spyre Therapeutics Inc | 3,533 | 178.2K $ | 0.61 % |
| 29 | Protagonist Therapeutics Inc | 1,650 | 173.9K $ | 0.60 % |
| 30 | TG Therapeutics Inc | 5,049 | 167.7K $ | 0.57 % |
| 31 | Arrowhead Pharmaceuticals Inc | 2,611 | 163.7K $ | 0.56 % |
| 32 | Catalyst Pharmaceuticals Inc | 6,583 | 163K $ | 0.56 % |
| 33 | Amneal Pharmaceuticals Inc | 12,984 | 161.4K $ | 0.55 % |
| 34 | Arcus Biosciences Inc | 7,459 | 161.1K $ | 0.55 % |
| 35 | Twist Bioscience Corp | 3,238 | 153.9K $ | 0.53 % |
| 36 | Ligand Pharmaceuticals Inc | 766 | 152.9K $ | 0.52 % |
| 37 | Mirum Pharmaceuticals Inc | 1,646 | 152.1K $ | 0.52 % |
| 38 | Travere Therapeutics Inc | 5,100 | 151.5K $ | 0.52 % |
| 39 | Alnylam Pharmaceuticals Inc | 456 | 150.9K $ | 0.52 % |
| 40 | Guardant Health Inc | 1,618 | 149.5K $ | 0.51 % |
| 41 | Roivant Sciences Ltd | 5,250 | 145.4K $ | 0.50 % |
| 42 | Moderna Inc | 2,836 | 144.1K $ | 0.49 % |
| 43 | Supernus Pharmaceuticals Inc | 2,776 | 143.5K $ | 0.49 % |
| 44 | Krystal Biotech Inc | 551 | 142.3K $ | 0.49 % |
| 45 | Tarsus Pharmaceuticals Inc | 2,012 | 141.1K $ | 0.48 % |
| 46 | Ionis Pharmaceuticals Inc | 1,872 | 140.6K $ | 0.48 % |
| 47 | 10X Genomics Inc | 6,591 | 139.9K $ | 0.48 % |
| 48 | Kymera Therapeutics Inc | 1,663 | 138.5K $ | 0.47 % |
| 49 | ACADIA Pharmaceuticals Inc | 6,186 | 137.7K $ | 0.47 % |
| 50 | Arcutis Biotherapeutics Inc | 5,633 | 132.7K $ | 0.45 % |
Sector breakdown
- Health care 77.3 %
- Unattributed 22.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 96.3 %
- Ireland 3.2 %
- Bermuda 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 47 | 28.1M $ | 96.31 % |
| 2 | Ireland | 2 | 929.1K $ | 3.19 % |
| 3 | Bermuda | 1 | 145.4K $ | 0.50 % |
Cite this page
Titelia. "Holdings of First Trust Nasdaq Pharmaceuticals ETF". https://titelia.com/en/funds/S000053945